COMPANY

Syracuse Biolabs, Inc.

Location: Camillus, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $534K (STTR Phase II 5R42GM140530-03, continuation, notice Jun 30, 2026). NIH RePORTER 5R42GM140530-03 (Jun 30, 2026)
Evidence (1 event)
- Jun 30, 2026 · NIH RePORTER 5R42GM140530-03
  Organization: SYRACUSE BIOLABS, INC.; City/State: CAMILLUS, NY; Project number: 5R42GM140530-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-06-30; FY total cost (award amount): 534278; Administering IC: National Institute of General Medical Sciences; Project title: Commercialization of a phylogenetic cell separation method for downstream purification of nucleic acids; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Jun 30, 2026 Grant Government grant — STTR: $534,278 (annual award, as published), announced Jun 30, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Jul 9, 2025 Grant Government grant — STTR: $510,862 (annual award, as published), announced Jul 9, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗

Last 2 years.

Jun 30, 2026 Government grant — STTR: $534,278 (annual award, as published), announced Jun 30, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Jul 9, 2025 Government grant — STTR: $510,862 (annual award, as published), announced Jul 9, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗